The macroepidemiology of influenza vaccination in 56 countries, 1997-2003

被引:101
作者
Fedson, DS [1 ]
Kunze, M [1 ]
Snacken, R [1 ]
Ottosen, AE [1 ]
Ruuskanen, O [1 ]
Cohen, JM [1 ]
Wutzler, P [1 ]
Constantopoulos, A [1 ]
Gudnason, T [1 ]
Domegan, L [1 ]
Donatelli, I [1 ]
van Essen, GA [1 ]
Haaheim, L [1 ]
de Andrade, HR [1 ]
Campins, M [1 ]
Portela, A [1 ]
Ortqvist, A [1 ]
Hagmann, R [1 ]
Leese, J [1 ]
Nguyen-Van-Tam, J [1 ]
Xibinaku, M [1 ]
Kojouharova, M [1 ]
Gjenero-Margan, I [1 ]
Tumova, B [1 ]
Vitkova, E [1 ]
Kerbo, N [1 ]
Baramidze, L [1 ]
Molnar, Z [1 ]
Kasymbekova, K [1 ]
Velicko, I [1 ]
Velga, K [1 ]
Ambrozaitis, A [1 ]
Scofertsa, PG [1 ]
Brydak, L [1 ]
Alexandrescu, V [1 ]
Lupulescu, E [1 ]
Rudenko, L [1 ]
Kristufkova, Z [1 ]
Socan, M [1 ]
Badur, S [1 ]
Moiseeva, AV [1 ]
Tursunova, D [1 ]
Tam, T [1 ]
Esqueda, AL [1 ]
O'Mara, D [1 ]
Savy, V [1 ]
Toniolo-Neto, J [1 ]
Maggi, L [1 ]
Singler, MM [1 ]
Bagnulo, H [1 ]
机构
[1] MIV Study Grp, F-01630 Sergy Haut, France
关键词
influenza vaccination; vaccination recommendations; vaccination reimbursement;
D O I
10.1016/j.vaccine.2005.06.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The WHO Global Agenda on Influenza calls for measuring the progress of national influenza vaccination programs. In response, the Macroepidemiology of Influenza Vaccination (MIV) Study Group has gathered information on influenza vaccination in 56 countries. During the period 1997-2003, influenza vaccine distribution increased considerably in almost all countries. In 2003, the countries with the highest levels of vaccination (doses distributed/1000 population) were Canada (344), the Republic of Korea (311), the United States (286) and Japan (230). Most countries recommended influenza vaccination for elderly persons and those with high-risk medical conditions, including immunocompromise. Fewer countries provided public reimbursement for vaccination through national or social health insurance. Higher levels of vaccination were not closely related to higher levels of economic development, but in many instances public reimbursement for vaccination seemed to be associated with greater vaccine use. From 1994 to 2003, the global use of influenza vaccines increased more than two-fold. In 2003, the 56 MIV Study Group countries accounted for approximately 95% of the 292 million doses of influenza vaccine distributed worldwide, and 62% of these doses were distributed within nine vaccine-producing countries in North America, Western Europe, Japan and Australia. However, influenza vaccination was increasing rapidly in many non vaccine-producing countries, and this change has important implications for pandemic vaccination. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5133 / 5143
页数:11
相关论文
共 27 条
[1]   Influenza vaccination in 29 countries - An update to 1997 [J].
Ambrosch, F ;
Fedson, DS .
PHARMACOECONOMICS, 1999, 16 (Suppl 1) :47-54
[2]  
Tablan Ofelia C, 2004, MMWR Recomm Rep, V53, P1
[3]  
[Anonymous], 2002, Wkly Epidemiol Rec, V77, P179
[4]  
[Anonymous], 2004, Wkly Epidemiol Rec, V79, P366
[5]  
[Anonymous], WORLD DEV IND DAT
[6]   Reye's syndrome in the United States from 1981 through 1997 [J].
Belay, ED ;
Bresee, JS ;
Holman, RC ;
Khan, AS ;
Shahriari, A ;
Schonberger, LB .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (18) :1377-1382
[7]   Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants [J].
Black, SB ;
Shinefield, HR ;
France, EK ;
Fireman, BH ;
Platt, ST ;
Shay, D .
AMERICAN JOURNAL OF PERINATOLOGY, 2004, 21 (06) :333-339
[8]   Influenza and pneumococcal vaccination of the elderly in Taiwan [J].
Chen, YH ;
Liou, SH ;
Chou, CC ;
Su, WL ;
Loh, CH ;
Lin, SH .
VACCINE, 2004, 22 (21-22) :2806-2811
[9]   INFLUENZA VACCINATION IN 18 DEVELOPED-COUNTRIES, 1980-1992 [J].
FEDSON, DS ;
HANNOUN, C ;
LEESE, J ;
SPRENGER, MJW ;
HAMPSON, AW ;
BROJORGENSEN, K ;
AHLBOM, AM ;
NOKLEBY, H ;
VALLE, M ;
OLAFSSON, O ;
GARCIA, FS ;
GUGELMAN, R ;
DEANDRADE, HR ;
SNACKEN, R ;
AMBROSCH, F ;
DONATELLI, I .
VACCINE, 1995, 13 (07) :623-627
[10]   Preparing for pandemic vaccination: An international policy agenda for vaccine development [J].
Fedson, DS .
JOURNAL OF PUBLIC HEALTH POLICY, 2005, 26 (01) :4-29